# A Canadian Study to Assess the Safety of Humate-P® Ivr (Infusion Volume Reduced)

> **NCT00701545** · — · COMPLETED · sponsor: **CSL Behring** · enrollment: 21 (actual)

## Conditions studied

- Von Willebrand Disease

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT00701545
- **Lead sponsor:** CSL Behring
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2008-02
- **Primary completion:** —
- **Final completion:** 2009-04
- **Target enrollment:** 21 (ACTUAL)
- **Last updated:** 2011-02-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00701545

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00701545, "A Canadian Study to Assess the Safety of Humate-P® Ivr (Infusion Volume Reduced)". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT00701545. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*